Cargando…
The PLGA nanoparticles for sustainable release of CGRP to ameliorate the inflammatory and vascular disorders in the lung of CGRP-deficient rats
The calcitonin gene-related peptide (CGRP) has been demonstrated relating to vascular and inflammatory regulations not only the nerve systems. As the anti-inflammation factor and the most potent vasodilator, the CGRP holds therapeutic potentials for the treatment of cardiovascular diseases which was...
Autores principales: | Wang, Fang, Deng, Yu, Wang, Jieting, Yu, Luying, Ding, Fadian, Lian, Wei, Liu, Qicai, Lin, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118460/ https://www.ncbi.nlm.nih.gov/pubmed/33960246 http://dx.doi.org/10.1080/10717544.2021.1902021 |
Ejemplares similares
-
CGRP and CGRP receptors in human and rhesus monkey cerebellum
por: Eftekhari, S, et al.
Publicado: (2013) -
CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009) -
CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016) -
The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow
por: Dux, Mária, et al.
Publicado: (2022) -
Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
por: Haanes, Kristian Agmund, et al.
Publicado: (2020)